Romanian IT Firm TotalSoft Secures €5.5 Million to Build AI-Powered Medical Interoperability Platform

Romanian IT firm TotalSoft secured a €5.5 million investment, with a €2.4 million EU grant, to build an AI‑powered platform that enables seamless data exchange between laboratory and hospital information systems, aiming for deployment in Romania and abroad by 2029.

Swiss Biotech Startup Vale Biolabs Secures €164k Grant to Advance AI-Driven Brain Disease Research Platform

Swiss biotech startup Vale Biolabs secured a €164k grant from the Swiss accelerator Venture Kick to accelerate its AI‑driven human brain organoid platform, aiming to improve pre‑clinical testing for neurological diseases and reduce reliance on animal models.

European Medtech Consortium Launches Battle Truck Initiative to Deliver Advanced Medical Evacuation to Ukraine

Battle Truck is a European‑led initiative to create a durable, technology‑rich medical evacuation vehicle for Ukraine’s war zone. Spearheaded by volunteer medic Howard Hunt, the project brings together Dutch vehicle‑engineering firm NIXXEN, UK’s Molecular Products, US‑based Velico, Estonia’s AO‑Med and Denmark’s Phoenix Denmark. The team is raising €500,000 to acquire a van and integrate the partner technologies, aiming to produce 3‑4 prototype trucks that can be tested on the front lines and later scaled for broader use.

Leipzig Healthtech Startup JawBuddy Secures €818,000 in Pre-Seed Funding for Digital Jaw Pain Therapy

Leipzig‑based health‑tech startup JawBuddy, which offers a digital self‑therapy app for jaw pain, bruxism and TMJ disorders, closed a €818k pre‑seed round led by the healthcare platform HALBZEIT. The funding will be used to launch clinical trials and seek reimbursement from statutory health insurers.

Norwegian Biotech Vitroscope Raises $7 Million to Scale Perfusion Platform for Drug Discovery

Swiss biotech Vitroscope secured $7 million (a $5 million seed round co‑led by Cerberus Ventures and YZR Capital and $2 million of non‑dilutive funding from the Research Council of Norway) to bring its automated perfusion platform for living human tissue to more labs and develop a higher‑throughput version. The funding brings the company’s total capital raised to $8.8 million.